Brown Seaweed Extract on Glycemic Control and Body Weight
Launched by LAVAL UNIVERSITY · Mar 6, 2017
Trial Information
Current as of May 07, 2025
Completed
Keywords
ClinConnect Summary
Diets that produce lower glucose and insulin responses may reduce diabetes and cardiovascular risk. They may also facilitate weight control by promoting satiety, insulin sensitivity and optimal insulin secretion after a meal. Food ingredients may indeed reduce postprandial glucose and insulin response through an inhibition of α-amylase and α-glucosidase activity that may slow down the absorption of carbohydrates. InSea2® is a unique combination of polyphenolic extracts of brown algae (Ascophyllum nodosum and Fucus vesiculosus) which has been shown to inhibit the action of α-amylase and α-gl...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • overweight (BMI \> 25; waist circumference ≥ 80cm for women and ≥ 94 cm for men)
- • fasting insulin (≥ 60 pmol/L)
- • Impaired fasting glycemia with or without impaired glucose tolerance
- • HbA1c between 5.6 and 6.4
- • non-smoking
- • stable weight in the past 3 months
- Exclusion Criteria:
- • diabetes
- • chronic disease (thyroid dysfunction, hepatic or gastrointestinal disorder, uncontrolled hypertension)
- • taking drugs that could affect glucose or lipid metabolism or weight and appetite
- • taking dietary supplements (protein powders, fish oil, omega-3 or any marine supplements) or natural health products that could affect glucose, lipid, weight or appetite
- • major surgery 3 months prior to the study
- • pregnancy
- • fish, seafood or iodine allergy
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Quebec, , Canada
Patients applied
Trial Officials
Hélène Jacques, PhD
Principal Investigator
Institue of Nutrition and Functional Food (INAF), Laval University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials